|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionAnnexins are a family of calcium-dependent phospholipid-binding proteins abundant in the eukaryotic kingdom. Annexin V's preferential binding partner is phosphatidylserine (PS). Under normal physiologic conditions, PS is predominantly located in the inner leaflet or cytosol-facing part of the plasma membrane. Upon initiation of apoptosis, PS loses its asymmetric distribution in the phospholipid bilayer and is translocated to the extracellular membrane leaflet where it identifies cells as targets of phagocytosis. Once on the outer surface of the membrane, PS can be detected by a fluorescently labeled annexin V in a Ca2+ -dependent manner. In early stage apoptosis, the plasma membrane excludes viability dyes such as propidium iodide and 7-AAD, so these cells will only stain with Annexin V and serves as an early marker of apoptosis. However, in late stage apoptosis, the cell membrane loses integrity allowing Annexin V to access PS in the interior of the cell, as well. A viability dye such as 7-AAD or propidium iodide (PI) can be used to resolve these late stage apoptotic and necrotic cells (Annexin V and 7-AAD or PI double positive) from the early stage apoptotic cells (Annexin V positive, 7-AAD or PI negative). Not included: Propidium Iodide Staining Solution (cat. 00-6990) Components:
Applications ReportedFor research use only, not for diagnostic or therapeutic use. FITC Recombinant Human Annexin V (Anxa5) has been reported for use in flow cytometric analysis. Applications TestedFITC Recombinant Human Annexin V (Anxa5) has been pre-titrated and tested on Jurkat cells treated with 10µM Camptothecin for 4 hours. This can be used at 5 μl per 1-5x105 cells in a 100 μl total staining volume. References
Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem. 1990; 265(9):4923-4928 Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994; 84(5):1415-1420 Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995; 184(1):39-51 Related ProductsCat. 00-6990 Propidium Iodide Staining Solution Cat. 00-6993 7-AAD Viability Staining Solution Cat. 88-8007 Annexin V-APC Apoptosis Detection Kit Annexin V Staining Protocol
Note: Due to the calcium dependence of the Annexin V : PS interaction, it is critical to avoid buffers containing EDTA or other calcium chelators during Annexin V experiments. Annexin V can only be used as a marker of apoptosis in cells where the plasma membrane is intact because destroying the integrity of the plasma membrane will allow non-specific binding of Annexin V to PS inside the cell. Pat. No. EP 181 465 B2, EP 0509 026, USP 5,066,787 |
||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |